Clinical Trials Logo

Post-Traumatic Headache clinical trials

View clinical trials related to Post-Traumatic Headache.

Filter by:
  • Not yet recruiting  
  • « Prev · Page 2

NCT ID: NCT05289414 Not yet recruiting - Clinical trials for Cervicogenic Headache

Radiofrquency Targeting Mid Cervical Medial Branches vs GON in Cervicogenic Headache

Start date: September 2022
Phase: Phase 2/Phase 3
Study type: Interventional

To detect the Clinical efficacy of pulsed radiofrequency treatment targeting the mid cervical medial branches versus greater occipital nerve for cervicogenic headache

NCT ID: NCT05213065 Not yet recruiting - Clinical trials for Post-Traumatic Headache

Assessment of the Efficacy of the Transnasal Sphenopalatine Ganglion Block in the Treatment of Chronic Daily Headache in Children and Adolescents.

SPG
Start date: February 5, 2022
Phase: N/A
Study type: Interventional

Primary Objective The primary objective of the study is to assess whether transnasal sphenopalatine ganglion block using the device TX360 reduces intensity and severity of the Post-Traumatic Headache in adolescents. Secondary Objectives The study will also evaluate: - Quality of life (QoL) - Intensity of the headache - Physical function - Sleep quality - Role function (measured by PEDMIDAS) - Adverse events

NCT ID: NCT04722913 Not yet recruiting - Clinical trials for Cervicogenic Headache

Relation Between Cervicogenic Headache and Forward Head Posture

Start date: February 15, 2021
Phase:
Study type: Observational

This study will be designed to determining whether there is a relationship between CGH and cervical posture which may potentially provide physical therapists with evidence supporting the assessment and treatment of abnormal posture in this patient group.

NCT ID: NCT03751306 Not yet recruiting - Surgery Clinical Trials

Aerobic Exercise and Transcranial Low Laser Therapy in Patients With Central Nervous System Injury

Start date: January 14, 2019
Phase: N/A
Study type: Interventional

Objective of this protocol will be to evaluate the parameters related to the function of the musculoskeletal and cardiorespiratory system, through a rehabilitation and training program for people with acquired central nervous system and multiple sclerosis. The study will consist of volunteers with acquired CNS lesions and multiple sclerosis of both sexes, between 18 and 85 years old, and who wander with or without aid devices, randomly divided into 3 groups: Group 1 (cardiopulmonary treatment), Group 2 (cardiopulmonary treatment and transcranial photobiomodulation application) and Group 3 (cardiopulmonary treatment and placebo laser). All groups will receive aerobic training on a treadmill (Moviment®) with the aid of a suspension equipment (BrainMov® Physical Activity Station). The transcranial photobiomodulation (laser diode, λ = 810 nm, beam area 0.028 cm², power of 100 mW, power density of 3.5 mW / cm², energy of 3 Joules / point and energy density of 107.1 J / cm2) will be applied on the skin / scalp and the International System 10-20 at points F7, F8 and AFz will be used as reference for irradiation. Muscular activation, heart rate variability, lung volumes and capacities, fatigability, exercise tolerance, cognition and quality of life will be evaluated before, during, at the end and after two months of rehabilitation. The treatment proposed in this study, using transcranial photobiomodulation, is expected to improve muscle, sensory, cardiorespiratory, cognitive functions and to interfere positively in the quality of life of the volunteers.